51,810 Baxter International Inc. $BAX Shares Purchased by Fulcrum Asset Management LLP

Fulcrum Asset Management LLP grew its stake in shares of Baxter International Inc. (NYSE:BAX) by 10,749.0% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,292 shares of the medical instruments supplier’s stock after buying an additional 51,810 shares during the period. Fulcrum Asset Management LLP’s holdings in Baxter International were worth $1,255,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in BAX. Jones Financial Companies Lllp bought a new position in shares of Baxter International during the 2nd quarter valued at approximately $26,000. CYBER HORNET ETFs LLC increased its holdings in Baxter International by 52.4% in the 2nd quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 740 shares in the last quarter. Community Bank N.A. bought a new stake in Baxter International during the 2nd quarter worth approximately $46,000. Versant Capital Management Inc raised its stake in Baxter International by 552.2% during the 2nd quarter. Versant Capital Management Inc now owns 2,413 shares of the medical instruments supplier’s stock worth $51,000 after acquiring an additional 2,043 shares during the period. Finally, EFG International AG bought a new stake in Baxter International during the 2nd quarter worth approximately $67,000. 90.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the stock. Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Barclays raised their price objective on shares of Baxter International from $20.00 to $23.00 and gave the company an “underweight” rating in a research report on Monday. JPMorgan Chase & Co. lowered their target price on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating on the stock in a research note on Friday, October 30th. Wells Fargo & Company lifted their target price on shares of Baxter International from $23.00 to $25.00 and gave the company an “equal weight” rating in a research note on Friday, October 30th. Finally, The Goldman Sachs Group upped their target price on shares of Baxter International from $19.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, July 15th. One analyst has rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, Baxter International has an average rating of “Reduce” and a consensus price target of $23.27.

Baxter International Stock Performance

NYSE:BAX opened at $26.37 on Thursday. The company has a current ratio of 1.79, a quick ratio of 1.19 and a debt-to-equity ratio of 1.20. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The stock has a 50-day moving average price of $24.53 and a 200 day moving average price of $21.61. The stock has a market capitalization of $13.64 billion, a P/E ratio of -18.70, a P/E/G ratio of 3.89 and a beta of 0.68.

Baxter International (NYSE:BAX) last issued its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.52 by $0.06. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The company had revenue of $2.98 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same quarter last year, the company earned $0.69 EPS. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. Equities research analysts forecast that Baxter International Inc. will post 2.10 EPS for the current fiscal year.

Baxter International Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s dividend payout ratio (DPR) is -2.84%.

Baxter International Company Profile

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.